Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EuroNet-Paediatric Hodgkin’s Lymphoma Group haematotoxicity comparison
2012-004053-88Phase 3Completed
- Sponsor
- Justus Liebig University Giessen
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of vincristine, etoposide, prednisone, doxorubicin, cyclophosphamide and 3 more in classical Hodgkin lymphoma (cHL) (2 arms), sponsored by Justus Liebig University Giessen. Primary endpoint: Primary efficacy endpoint. Started Jan 2015; status: completed.
02
Drugs
vincristineetoposideprednisonedoxorubicincyclophosphamide
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on 2012-004053-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004053-88.